Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.

The Tohoku journal of experimental medicine - 1 Mar 2015

Zhang Xiuling, Li Ping, Rong Minhua, He Rongquan, Hou Xinxi, Xie You, Chen Gang

Abstract excerpt

Lung cancer is the most common malignant tumor worldwide. MicroRNA has become an ideal biomarker for cancer diagnosis, prognosis and therapy. The relationship between microRNA-141 and non-small cell lung cancer (NSCLC) is contradictory. Thus, in current study, we aimed to investigate the level of microRNA-141 in NSCLC tissues and to evaluate its potential clinical value. This study enrolled 125 NSCLC patients (75...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Squamous Cell

Share to ErbB Receptors

Share to Kaplan-Meier Estimate

Share to MicroRNAs

Share to Protein Kinase Inhibitors

Share to Survival Analysis

Source

Identifiers

PMID: 25746592
DOI: 10.1620/tjem.235.161

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-141 is a biomarker for progression of squamous cell carcinoma and adenocarcinoma of the lung: clinical analysis of 125 patients.PMID 25746592Read ↗

Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR dataSemantic proximity Read ↗

Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib.Semantic proximity Read ↗

Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.Semantic proximity Read ↗

Integrative Bioinformatics Analysis Identifies Noninvasive miRNA Biomarkers for Lung CancerSemantic proximity Read ↗

Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer.Semantic proximity Read ↗

MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLCSemantic proximity Read ↗

miR‑140‑3p enhances cisplatin sensitivity and attenuates stem cell‑like properties through repressing Wnt/β‑catenin signaling in lung adenocarcinoma cellsSemantic proximity Read ↗

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsSemantic proximity Read ↗

Plasma miR ‐1247‐5p, miR ‐301b‐3p and miR ‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancerSemantic proximity Read ↗

Critical microRNAs in Lung Cancer: Recent Advances and Potential ApplicationsSemantic proximity Read ↗

Association between polymorphisms in pre-miRNA genes and risk of lung cancer in a Chinese non-smoking female population.Semantic proximity Read ↗

Expression and Diagnostic Efficacy of miR-126-5p and miR-34c-3p in Serum Extracellular Vesicles of Non-Small Cell Lung Cancer PatientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.